We supply medical testing to medical standards from a medical laboratory to help diagnose medical conditions.
Our Colon Cancer laboratory test is an accurate test measuring intestinal inflammation. When the colon is inflamed or diseased a protein called Calprotectin is found in the stool. Research shows that the levels of calprotectin found in the stool samples are raised with certain bowel conditions, Low levels indicate irritable bowel conditions and higher levels indicate inflammatory bowel disease such as Chrohns Disease or Ulcerative colitis or Adenamatous polyps. Sufficiently high levels are a strong indicator of the possibility of precancerous polyps and higher levels indicate the possibility of colon cancer.
If the calprotectin test is strongly positive then it indicates that more invasive and specific examinations such as colonoscopy may be required. If the calprotectin test is negative, then it is highly unlikely that you have any of the bowel conditions mentioned. If there are symptoms, other medical investigations may be necessary and your GP should be consulted.
This test is as reliable as a colonoscopy. If a colon polyp is discovered at an early stage your survival rate is 90%-100% as it can be easily removed before it becomes cancerous.
Colon cancer is the second most common tumour or cancer in the United Kingdom. One in every twenty seven people will suffer with colon cancer. The risk is one in fifteen if a first degree relative has been affected. The risk rises considerably if more members of the family are affected. Early detection increases survival rates by over 90%.
The average age when colon cancer is diagnosed is between 60-65 years. Colon Cancer is more common in the Western world as we have a high consumption of meat and dairy products, with low consumption of dietary fibre. These factors tend to slow down transit through the bowel and increase time for a potential colon cancer agent to remain in contact with the bowel wall.
Colon Cancer is a general term which is usually called Colorectal cancer by the medical profession. This is because the colon and the rectum are a continuous organ. The National Cancer Institute defines Colon Cancer as a cancer that forms in the tissues of the colon, (the longest part of the large intestine). Most colon cancers are Adenocarcenomas , or cancers that begin in cells that make and release mucus and other fluids. Rectal cancer is a cancer that forms in the tissues of the rectum. (This is the last several inches of the large intestine before the anus)
Most colorectal cancers, (including colon cancers), progress from the colon wall being normal, to a colon polyp (LINK) forming in the colon wall. The polyp or polyps develop to invasive colon cancer. Early detection is vital as the prognosis of colon cancer treatment depends on intervention at an early level. A five year colon cancer survival rate at the earliest stage will be 90%-100%. This is when the colon cancer is likely to have no symptoms at all. Sadly, only one in ten people with colon cancer present at this early stage. This is why colon cancer is known as ‘the silent killer’. Once the colon cancer has spread from this early stage the survival rate reduces dramatically.
It has been recommended that all adults begin regular screening for colon cancer at the age of 50 years.
Advantages and Disadvantages of Different Colorectal Cancer Screening Tests
Test |
Advantages |
Disadvantages |
Calprotectin Stool Test |
|
|
Faecal Occult Blood Test |
|
|
Blood Count and Routine Biochemistry |
|
|
Digital Rectal Examination |
|
|
Colonoscopy |
|
|
Sigmoidoscopy |
|
|
A colon polyp is an elevated area above the inner surface of the colon. The majority of colorectal polyps are adenomas with malignant potential. They are common and 90% of colon polyps are innocent. Most colon polyps are asymptomatic and are found by chance when other things are investigated, such as pain, altered bowel habit, bleeding haemorrhoids or other reasons.
A tumour is a mass of cells or lump which has no useful function. The cells divide and grow and can be either benign or malignant. Another name for a tumour is a neoplasm
A tumour grade is a system used to classify cancer cells by how abnormal they look under the microscope and how quickly the tumour is likely to spread and grow
A stage is a standardised way that a cancer is described. It is based on how far the cancer has grown into the wall of the colon and whether it has spread to near or distant structures or to the lymph nodes. The most common staging system used in America is the TNM system. There are older systems of classifying colorectal carcinoma or colon cancer such as The Duke’s Classification and The Astler-Coller System. Some Doctors may use different classifications in describing a tumour. The National Health Service in the United Kingdom use The Dukes Classification.
There are three types of staging.
The clinical stage determines how much cancer there is based on the physical examination, imaging investigations such as MRI scans, or CT scans and any biopsies.
Pathologic Staging can only be done when surgery has been done to remove or explore the extent of the cancer. The results of the clinical stage and this are combined.
Restaging occurs if a cancer returns after treatment. This type of staging is less common
Dukes |
Description |
% of cases |
5 year Survival Rate |
A |
Colon Cancer confined to Bowel Wall |
10% |
90-100% |
B |
Colon Cancer extending beyond bowel wall, but without metastases |
35% |
65-75% |
C |
Colon Cancer involving lymph nodes |
30% |
30-40% |
D |
Cancer with distant metastases or with residual disease following surgery |
25% |
Less than 5% |
Neutrophils are the most common type of white blood cell, comprising about 50-70% of all white blood cells and are part of the body’s immune system. They are a type of white blood cell known as a granulocyte. Granulocytes contain substances which release into the body when they ingest (eat) cells which the body recognises as ‘foreign’ Neutrophils are phagocytic, meaning that they can ingest other cells and they do not survive once they have done this. Neutrophils are granulocytes, which means that they contain calprotectin within their cytosol. Neutrophils are the first immune cells to arrive at a site of infection, through a process known as chemotaxis. They are an important part of the immune response and are present in the blood and attracted to sites of infection. They ingest any pathogen or foreign cells and once they die Calprotectin is released.
Plasma concentrations of Calprotectin are raised in diseases involving increased neutrophil activity. During any condition increasing intestinal inflammation the neutrophils travel from the blood through the intestinal wall. They commence ingesting cells of disease. Once they have ingested a disease cell they die and the Calprotectin held in their cytosol is released into the bowel. Calprotectin is then detectable in the faeces. Research shows that faecal calprotectin is significantly increased in intestinal diseases such as Inflammatory Bowel Disease (IBD), Crohn's disease, colorectal inflammation, ulcerative colitis, necrotizing enterocolitis and in colon cancer.
Calprotectin is stable at room temperature and allows for samples to be sent to our laboratory by post.